Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
CorrectionFull Access

CORRECTION

Published Online:1 Mar 2019https://doi.org/10.1176/appi.ajp.2019.1763correction

When the article “Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis,” by Jian-Ping Zhang et al. (doi: 10.1176/appi.ajp.2018.17121363) was published online on November 5, 2018, and in the January 2019 issue, Dr. Benedicto Crespo-Facorro’s affiliation should have been listed as the Department of Medicine and Psychiatry, University of Cantabria, CIBERSAM, IDIVAL, University Hospital Marqués de Valdecilla, Santander, Spain. This correction was made for the online edition on February 7, 2019.